Excessive maternal caffeine exposure during pregnancy is cataractogenic for neonatal crystalline lenses in rats: A biomicroscopic and histopathologic study

Acta Ophthalmologica Scandinavica

Volumn 82, Issue 5, 2004, Pages 552-556

  Evereklioglu, Cem ^a,c   Güldür, Emin ^b   Alasehirli, Belgin ^b   Cengiz, Beyhan ^b   Sari, Ibrahim ^b   Pirbudak, Lütfiye ^b  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

^b GAZIANTEP UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Caffeine; Cataract; Crystalline lens; Neonatal rats; Pregnancy

Indexed keywords

CAFFEINE; SODIUM CHLORIDE; WATER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMICROSCOPY; CATARACT; CATARACTOGENESIS; CELL DEGENERATION; CELL NUCLEUS; CELL SWELLING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; COPULATION; DECAPITATION; DELIVERY; EOSINOPHIL; EPITHELIUM CELL; EXPERIMENTAL MODEL; FEEDING; FEMALE; GESTATION PERIOD; HISTOPATHOLOGY; IN VIVO STUDY; LENS; LENS CAPSULE; LENS EPITHELIUM; LENS FIBER; LIQUEFACTION; MALE; MATERNAL BEHAVIOR; MATING; NEWBORN; NONHUMAN; PERINATAL PERIOD; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; RAT; SLIT LAMP; VAGINA SMEAR; VISUAL SYSTEM EXAMINATION;

ANIMALS; ANIMALS, NEWBORN; CAFFEINE; CATARACT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; LENS, CRYSTALLINE; MALE; PREGNANCY; PREGNANCY, ANIMAL; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, WISTAR;

EID: 6344287622     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2004.00331.x     Document Type: Article

References (48)

1. Aldridge A, Bailey J & Neims AH (1981): The disposition of caffeine during and after pregnancy. Semin Perinatol 5: 310-314.
2. Arushanian EB & Ovanesov KB (1999): Effect of caffeine on the light sensitivity of the retina of the eye in healthy humans. Fiziol Cheloveka 25: 124-126.
3. Avisar R, Avisar E & Weinberger D (2002): Effect of coffee consumption on intraocular pressure. Ann Pharmacother 36: 992-995.
4. Bottcher M, Czernin J, Sun KT, Phelps ME & Schelbert HR (1995): Effect of caffeine on myocardial blood flow at rest and during pharmacological vasodilation. J Nucl Med 36: 2016-2021.
5. Cameron OG, Modell JG & Hariharan M (1990): Caffeine and human cerebral blood flow: a positron emission tomography study. Life Sci 47: 1141-1146.
6. Committee on Educational Programmes in Laboratory Animal Science (1991): Education and Training in the Care and Use of Laboratory Animals: a Guide for Developing Institutional Programmes. Washington: Institute of Laboratory Animal Resources, National Research Council, USA.
7. Concannon JT, Braughler JM & Schechter MD (1983): Pre- and postnatal effects of caffeine on brain biogenic amines, cyclic nucleotides and behaviour in developing rats. J Pharmacol Exp Ther 226 673-679.
8. Devoe LD, Murray C, Youssif A & Arnaud M (1993): Maternal caffeine consumption and fetal behaviour in normal third-trimester pregnancy. Am J Obstet Gynecol 168: 1105-1111.
9. Doganay S, Turkoz Y, Evereklioglu C, Er H, Borazan M & Ozerol E (2002): Use of caffeic acid phenethyl ester to prevent sodium-selenite-induced cataract in rat eyes. J Cataract Refract Surg 28: 1457-1462.
10. Evereklioglu C, Alasehirli B, Sari I, Cengiz B & Bagci C (2004): Effect of nicotine exposure during gestation on neonatal rat crystalline lenses. Eye 18: 67-73.
11. Evereklioglu C, Ozkiris A, Alasehirli B, Sari I, Güldür E, Cengiz B & Kontas O (2003): Effect of gestational nicotine treatment on newborn rat retina: a histopathological and morphometric analysis. Ophthalmic Physiol Optics 23: 527-533.
12. Fernandes O, Sabharwal M, Smiley T, Pastuszak A, Koren G & Einarson T (1998): Moderate to heavy caffeine consumption during pregnancy and relationship to spontaneous abortion and abnormal fetal growth: a meta-analysis. Reprod Toxicol 12: 435-444.
13. Food and Drug Administration (1980): Caffeine and pregnancy. FDA Drug Bull 10: 19-20.
14. Fortier I, Marcoux S & Beaulac-Baillargeon L (1993): Relation of caffeine intake during pregnancy to intrauterine growth retardation and preterm birth. Am J Epidemiol 137: 931-940.
15. Graham DM (1978): Caffeine - its identity, dietary sources, intake and biological effects. Nutr Rev 36: 97-102.
16. Hepsen IF, Bayramlar H, Gultek A, Ozen S, Tilgen F & Evereklioglu C (1997): Caffeic acid phenylethyl ester to inhibit posterior capsule opacification in rabbits. J Cataract Refract Surg 23 1572-1576.
17. Higginbotham EJ, Kilimanjaro HA, Wilensky JT, Batenhorst RL & Hermann D (1989): The effect of caffeine on intraocular pressure in glaucoma patients. Ophthalmology 96: 624-626.
18. Inaloz HS, Inaloz; SS, Deveci E & Eralp A (2000): Teratogenic effect of nicotine on rat skin. Clin Exp Obstet Gynecol 27: 241-243.
19. Infante-Rivard C, Fernandez A, Gauthier R, David M & Rivard GE (1993): Fetal loss associated with caffeine intake before and during pregnancy. JAMA 270: 2940-2943.
20. Jiritano L, Bortolotti A, Gaspari F & Bonati M (1985): Caffeine disposition after oral administration to pregnant rats. Xenobiotica 15: 1045-1051.
21. Kimmel CA, Kimmel GL, White CG, Grafton TF, Young JF & Nelson CJ (1984): Blood flow changes and conceptual development in pregnant rats in response to caffeine. Fundam Appl Toxicol 4: 240-247.
22. Kirkinen P, Jouppila P, Koivula A, Vuori J & Puukka M (1983): The effect of caffeine on placental and fetal blood flow in human pregnancy. Am J Obstet Gynecol 147: 939-942.
23. Klintworth GK & Eagle RC Jr (1999): The eye and ocular adnexa. In: Stephen SS (ed). Diagnostic Surgical Pathology. 3rd edn. Philadelphia: Lippincott, Williams & Wilkins 975-1007.
24. Klintworth GK & Garner A (1994): The causes, types and morphology of cataract. In: Garner A & Klintworth GK (eds). Pathology of Ocular Disease: a Dynamic Approach. 2nd edn. New York: Marcel Dekker 2211-2255.
25. Knutti R, Rothweiler H & Schlatter C (1981): Effect of pregnancy on the pharmacokinetics of caffeine. Eur J Clin Pharmacol 21 121-126.
26. Knutti R, Rothweiler H & Schlatter C (1982): The effect of pregnancy on the pharmacokinetics of caffeine. Arch Toxicol 5 (Suppl): 187-192.
27. Kurata K, Maeda M, Nishida E, Tsukuda R, Suzuki T, Ando T & Tokuriki M (1997): Relationship between caffeine-induced ocular hypertension and ultrastructure changes of non-pigmented ciliary epithelial cells in rats. J Toxicol Sci 22: 447-454.
28. Lane AJ, Coombs RC, Evans DH & Levin RJ (1999): Effect of caffeine on neonatal splanchnic blood flow. Arch Dis Child Fetal Neonatal Ed 80: 128-129.
29. Lotfi K & Grunwald JE (1991): The acute effect of caffeine on the human macular circulation. Invest Ophthalmol Vis Sci 32: 3028-3032.
30. Mathew RJ, Barr DL & Weinman ML (1983): Caffeine and cerebral blood flow. Br J Psychiatry 143: 604-608.
31. Matsuoka R, Uno H, Tanaka H, Kerr CS, Nakazawa K & Nadal-Ginard B (1987): Caffeine induces cardiac and other malformations in the rat. Am J Med Genet 3 (Suppl): 433-443.
32. Nehlig A & Debry G (1994): Potential teratogenic and neurodevelopmental consequences of coffee and caffeine exposure: a review on human and animal data. Neurotoxicol Teratol 16: 531-543.
33. Ojofeitimi EO, Adelekan DA, Adeoye A, Ogungbe TG, Imoru AO & Oduah EC (1999): Dietary and lifestyle patterns in the aetiology of cataracts in Nigerian patients. Nutr Health 13: 61-68.
34. Okimi PH, Sportsman S, Pickard MR & Fritsche MB (1991): Effects of caffeinated coffee on intraocular pressure. Appl Nurs Res 4 72-76.
35. Okuno T, Sugiyama T, Tominaga M, Kojima S & Ikeda T (2002): Effects of caffeine on microcirculation of the human ocular fundus. Jpn J Ophthalmol 46: 170-176.
36. Ovanesov KB (1998): The effect of caffeine on the colour-discriminating function of the retina in volunteers. Eksp Klin Farmakol 61: 17-19.
37. Ozkiris A, Evereklioglu C, Kontas O, Oner AO & Erkilic K (2004): Determination of non-toxic concentration of pipercilline/ tazobactam for intravitreal application: an electrographic, histopathologic and morphometric analysis. Ophthalmic Res 36: 139-144.
38. Rogers JM & Grabowski CT (1984): Postnatal mirex cataractogenesis in rats: lens action balance, growth and histology. Exp Eye Res 39: 563-573.
39. Roy TS, Andrews JE, Seidler FJ & Slotkin TA (1998): Nicotine evokes cell death in embryonic rat brain during neurulation. J Pharmacol Exp Ther 287: 1136-1144.
40. Scott WJ Jr (1983): Caffeine-induced limb malformations: description of malformations and quantitation of placental transfer. Teratology 28: 427-435.
41. Stubbs TA & Macdonald IA (1995): Systemic and regional haemodynamic effects of caffeine and alcohol in fasting subjects. Clin Auton Res 5: 123-127.
42. Thayer PS & Palm PE (1975): A current assessment of the mutagenic and teratogenic effects of caffeine. CRC Crit Rev Toxicol 3 345-369.
43. Weathersbee PS & Lodge JR (1977): Caffeine: its direct and indirect influence on reproduction. J Reprod Med 19: 55-63.
44. West GL, Sobotka TJ, Brodie RE, Beier JM & O'Donnell MW Jr (1986): Postnatal neuro-behavioral development in rats exposed in utero to caffeine. Neurobehav Toxicol Teratol 8: 29-43.
45. Wilkinson JM & Pollard I (1994): In utero exposure to caffeine causes delayed neural tube closure in rat embryos. Teratog Carcinog Mutagen 14: 205-211.
46. Wilson JG & Scott WJ (1984): The teratogenic potential of caffeine in laboratory animals. In: Dews PD (ed). Caffeine: Perspectives from Recent Research. Berlin: Springer-Verlag 165-187.
47. Wink CS, Rossowska MJ & Nakamoto T (1996): Effects of caffeine on bone cells and bone development in fast-growing rats. Anat Rec 246: 30-38.
48. Zhai H, Goss DA & Hammond RW (1993): The effect of caffeine on the accommodative response/accommodative stimulus function and on the response AC/A ratio. Curr Eye Res 12: 489-499.